The prevalence and risk of mortality associated with antimicrobial resistance within nosocomial settings-a global systematic review and meta-analysis of over 20,000 patients

  27 October 2025

This systematic review and meta-analysis of 34 studies involving over 20,000 hospitalised patients found that antimicrobial resistance (AMR) is highly prevalent in hospitals worldwide (36.5%) and significantly increases the risk of in-hospital mortality (adjusted pooled risk ratio 1.58, 95% CI 1.33–1.87) compared with non-resistant infections. Most data originated from high- and middle-income countries (e.g. USA, China, UK, Japan), while no studies were identified from Africa, the Middle East, Russia, or India. The evidence suggests particularly elevated mortality risks for AMR-associated bacteraemia. Despite generally high study quality, publication bias and limited mechanistic modelling were noted, and the overall certainty of evidence for mortality was low. The findings highlight AMR as a major in-hospital threat, underscoring the urgent need for research and interventions in underrepresented regions to curb AMR transmission and reduce hospital mortality.

Further reading: EClinicalMedicine
Author(s): Nisha A George et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!